Reprogramming of the miRNA networks in cancer and leukemia
Datasets
The expression data analyzed in this study can be accessed at the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession nos. GSE8126 and GSE7055 (Ambs et al. 2008) , GSE17155 ), GSE3467 (He et al. 2005) , GSE7828 (Schetter et al. 2008) , GSE6857 (Budhu et al. 2008) , GSE16654 (Chin et al. 2009 ), and GSE14936 (Seike et al. 2009 ), and at ArrayExpress (www.ebi.ac.uk/microarray-as/ae) under accession nos. E-TABM-866 (Pineau et al.) , E-TABM-664 (Bloomston et al. 2007 ), E-TABM-762 and E-TABM-763 (Visone et al. 2009 ), E-TABM-508 (Pichiorri et al. 2008 ) , E-TABM-429 (Garzon et al. 2008a ), E-TABM-434 ), E-TABM-405 (Garzon et al. 2008b ), E-TABM-343 (Iorio et al. 2007 ), E-TABM-41 and E-TABM-42 ), E-TABM-48 ), E-TABM-22 (Yanaihara et al. 2006 ), E-TABM-23 ), E-TABM-46, E-TABM-47, E-TABM-49, and E-TABM-50 , and E-MEXP-1796 (Godlewski et al. 2008 ), E-TABM-37 (Ciafre et al. 2005 ), E-TABM-341 (Ueda et al.) . The additional samples we used here were unpublished or previously reported in context-specific papers Garzon et al. 2006; Garzon et al. 2007; Zhang et al. 2008 ). The respective accession numbers are: E-TABM-969 and E-TABM-970 for normal tissues, E-TABM-971 for breast cancer, E-TABM-972 and E-TABM-974 for acute myeloid leukemia, E-TABM-973 for chronic lymphocytic leukemia and E-TABM-975 for ovarian cancer.
Supplemental Results and Discussion
The miRNA specificity and network in normal tissues and ES differentiation. Embryonic cell types, such as embryonic bodies, trophoblasts, endoderm, or other stem cells including induced pluripotent stem cells (iPS) also harbored high levels of hsa-miR-302. Since hsa-miR-302 expression only partially decreased throughout these stages of ES differentiation, its IC in embryonic tissues was low (0.5). The miRNAs which had highest tissue specificity in embryos were: hsa-miR-211 in 14 day embryoid bodies (EBs), hsa-miR-10b, hsa-miR-218, hsa-miR-122, and hsa-miR-148a in spontaneous differentiated monolayers, hsa-miR-138 and hsa-miR-338-3p in 7 day EBs, and hsa-miR-99a in trophoblast (Supplemental Figure 2 and Supplemental Table   III ). The information content (IC) of hsa-miR-302 genes is in our datasets even higher than that found by Landgraf, who considered a lower number of tissues/organs/systems. After hsa-miR-302, the most specific miRNAs are hsa-miR-338-5p, hsa-miR-323-3p, hsa-miR-335, with highest expression in epidermis/nervous system, nervous system and breast respectively (Supplemental Figure 1 and Supplemental Table I ). hsa-miR-122 is the miRNA with the highest IC difference between ours and the sequencing dataset. hsa-miR-371-5p is here well represented in embryonic cell types, since we have high hsa-miR-371-5p expression in embryoid bodies, not assayed in the clones' dataset. hsa-miR-129-3p is specific for nervous system in both datasets. We detected hsa-miR-142-5p in hematopoietic system and connective tissues. hsa-miR-9, hsa-miR-128 and hsa-miR-138 were nervous system specific in both datasets. We report twice as many different tissue groups that in the clones' dataset, thus we expected less tissue specific miRNAs and lower information contents. Our hypothesis is confirmed by the IC table (Supplemental Table I ). Nevertheless, the IC distributions are very similar: 25 miRNAs with IC higher than 1.35 for the microarrays, in comparison to 29 for the clones. The only notable exception to the lower IC is hsa-miR-302a/b/c. This variation might be due to the fact that we assayed different cell types of embryonic origin, in comparison to only ES cells for the clones.
Supplemental Methods
Tissue specificity. First, all samples were classified according to their organ-, tissue-and celltype; then the normal samples were grouped in specific systems and the disease samples in specific pathological states. To assess the specificity of miRNA expression across groups, we needed to estimate what fraction of the total, for a given miRNA belonged to each single group. Therefore, we used the procedure described in the first miRNA expression atlas (Landgraf et al. 2007) , with the only exception that we called Em,t the value of miRNA m in the group t referred to as "mean expression value (subtracted of the background value, 100). From here onwards, we essentially proceeded as the reference. The specificity score varies between 0, when the expression level of the miRNA m is the same across all tissues, and log2 of the number of tissue types, when only one tissue expresses the miRNA. To minimize artifacts from miRNAs or tissues with very small expression levels, we considered only miRNAs with a total expression value above 10 times the number of normal tissues and above 100 times the number of cancer types; with a minimal expression value (after background subtraction) of 100. For the calculation of overall specificity, we thus included 130 and 133 different mature miRNAs for normal tissues and cancer, respectively. Therefore, it is possible that we missed some specifically expressed miRNAs that in our data had either very low expression or were specific to tissues/diseases that we did not sample sufficiently.
Array CGH. Each cancer sample was compared to a healthy control on a two channel oligonucleotide-based platform. Each gene was evaluated in each sample by using the normalized log2 ratio (cancer over control). Different probes related to the same gene were averaged (gene symbols were used as keys). Data were normalized according to the providers. Bootstrap analysis (random swap between cancer and control channels) was used to simulate gene specific 5 th and 95 th percentiles. Gene-specific p-values for deletions were calculated as the percentage of resampled 5 th percentiles which exceeded the original 5 th percentile. We had to take in consideration two phenomena, associated to aCGH, but not linked to cancer: sex chromosomes and polymorphic copy number variations (CNV). Since the control sample was more frequently from male, while roughly half of the tumors were of female origin, the Ychromosome genes were incorrectly expected to appear as deleted. Conversely, we expected the X chromosome genes, except for those belonging to the pseudo-autonomic region, to incorrectly appear as amplified. Genes located in the sex chromosomes were indeed behaving exactly as expected (data not shown). Polymorphic CNVs could also display large fold-changes, resulting in high 95 th or low 5 th percentiles. But, we expected that such CNVs, not associated to cancer, would not display significant p-values. Indeed, most polymorphic sites for copy number variations (CNVs) did not filtered through the aCGH assay, since the different alleles were balanced in the cancer and control groups. Only a small percentage of miRNA coincided with polymorphic CNVs and that fraction was not enriched in the cancer subset (data not shown). :197,094,796-197,094,905 9:126,494,542-126,494,651 hsa-miR181b Trophoblast / Monolayer 8290 / 3397 0.93 1:197,094,625-197,094,734 9:126,495,810-126,495,898 hsa-miR-192 Monolayer Figure 1 . miRNA specificity in 50 normal tissues grouped by system. The tissue specificity was calculated by using the information content (IC), value expressed on y-axis; each color represents a system. The hsa-miR-302 cluster is the most representative for embryonic tissues.
Supplemental
Supplemental Figure 2 . The miRNA specificity during ES cell differentiation. miRNA specificity in 7 different types of embryonic tissues (embryonic stem cells, 7 days and 14 days embryonic bodies, trophoblasts, endoderm, induced pluripotent stem cells (iPS), spontaneously differentiating monolayers). The specificity was calculated by using the information content (IC). ) targeted by up-regulated miRNAs (listed in Table I and Supplemental Tables IV). Target genes selection was performed with DIANA-miRpath, microT-V4.0 (Papadopoulos et al. 2009 ). The union of the target mRNAs with a score above 3 was used as an input to ClueGO. Right-sided hyper-geometric test yielded the enrichment for GO-terms. Benjamini-Hochberg correction for multiple testing controlled the p-values. GO term fusion was applied for redundancy reduction. subnets). The network was inferred for all expressed and varying miRNAs, without preselecting for differential expression. Standard Banjo parameters were adopted with a q6 discretization policy. The consensus graph depicted here was obtained from the best 100 nets (after searching through >1x10

